1. Intravenous Immunoglobulins as a Treatment for Alzheimer’s Disease

   • Richard Dodel
   • Frauke Neff
   • Wolfgang Oertel

   Leading Article 17 September 2012 Pages: 513 - 528

   

2. B Cell-Targeted Therapies for Systemic Lupus Erythematosus

   • R. John Looney

   Leading Article 17 September 2012 Pages: 529 - 540

   

3. Nomegestrol Acetate

   • Stefano Lello

   Review Article 17 September 2012 Pages: 541 - 559

   

4. Advances in the Pharmacological Management of Huntington’s Disease

   • Samuel Frank
   • Joseph Jankovic

   Review Article 17 September 2012 Pages: 561 - 571

   

5. Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice

   • Attila S. Farkas
   • Stanley Nattell

   Review Article 17 September 2012 Pages: 573 - 603

   

6. Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs

   • Aaron S. Kesselheim
   • Margaret R. Stedman
   • William H. Shrank

   Original Research Article 17 September 2012 Pages: 605 - 621

   

7. Histrelin

   • Emma D. Deeks

   Adis Drug Profile 17 September 2012 Pages: 623 - 630

   

8. Raltegravir

   • Jamie D. Croxtall
   • Lesley J. Scott

   Adis Drug Profile 17 September 2012 Pages: 631 - 642